ProfileGDS4718 / 224844_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 91% 95% 92% 93% 90% 87% 92% 92% 92% 94% 92% 90% 89% 89% 94% 93% 91% 88% 90% 92% 91% 93% 93% 94% 89% 93% 82% 92% 90% 91% 91% 90% 94% 89% 86% 88% 91% 91% 97% 91% 87% 90% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6723292
GSM549102patient 115, normal, homogenized [OPG study]9.420191
GSM549104patient 119, normal, homogenized [OPG study]10.413695
GSM549108patient 138, normal, homogenized [OPG study]9.4473792
GSM549119patient 077, normal, homogenized [OPG study]9.7809493
GSM549133patient 032, cancer, homogenized [OPG study]9.3612890
GSM549139patient 042, cancer, homogenized [OPG study]8.8092587
GSM549099patient 107, normal, homogenized [OPG study]9.4351592
GSM549109patient 139, normal, homogenized [OPG study]9.6600992
GSM549110patient 046, normal, homogenized [OPG study]9.7213792
GSM549114patient 063, normal, homogenized [OPG study]10.191294
GSM549122patient 082, normal, homogenized [OPG study]9.6427292
GSM549134patient 033, cancer, homogenized [OPG study]9.1636590
GSM549136patient 036, cancer, homogenized [OPG study]9.0464989
GSM549140patient 044, cancer, homogenized [OPG study]9.1528789
GSM549111patient 047, normal, homogenized [OPG study]10.070794
GSM549113patient 057, normal, homogenized [OPG study]9.857693
GSM549132patient 031, cancer, homogenized [OPG study]9.3666691
GSM549137patient 038, cancer, homogenized [OPG study]8.8374888
GSM549142patient 047, cancer, homogenized [OPG study]8.6788790
GSM549100patient 110, normal, homogenized [OPG study]9.523692
GSM549107patient 135, normal, homogenized [OPG study]9.5301691
GSM549115patient 068, normal, homogenized [OPG study]9.9225393
GSM549116patient 072, normal, homogenized [OPG study]9.8878993
GSM549120patient 078, normal, homogenized [OPG study]9.9490594
GSM549131patient 030, cancer, homogenized [OPG study]9.1492689
GSM549118patient 074, normal, homogenized [OPG study]9.9250593
GSM549129patient 027, cancer, homogenized [OPG study]8.0900582
GSM549123patient 088, normal, homogenized [OPG study]9.5678892
GSM549124patient 006, cancer, homogenized [OPG study]9.0980590
GSM549126patient 015, cancer, homogenized [OPG study]9.3546391
GSM549128patient 025, cancer, homogenized [OPG study]9.2953991
GSM549103patient 117, normal, homogenized [OPG study]9.1837490
GSM549117patient 073, normal, homogenized [OPG study]10.212994
GSM549138patient 041, cancer, homogenized [OPG study]9.0602389
GSM549141patient 045, cancer, homogenized [OPG study]8.7568686
GSM549130patient 028, cancer, homogenized [OPG study]8.7906688
GSM549101patient 111, normal, homogenized [OPG study]9.2434291
GSM549105patient 128, normal, homogenized [OPG study]9.2581791
GSM549106patient 134, normal, homogenized [OPG study]10.91597
GSM549112patient 048, normal, homogenized [OPG study]9.4975591
GSM549125patient 011, cancer, homogenized [OPG study]8.7182687
GSM549127patient 024, cancer, homogenized [OPG study]9.0972990
GSM549135patient 035, cancer, homogenized [OPG study]8.6965886